Member Board of Directors, Chairman Governance Committee @ Oncolytics Biotech Inc. (Nasdaq: ONCY) (September 2022 - Present)
Board Member @ (October 2020 - Present)
Chairman and CBO @ BIOS Acquisition Corporation (July 2021 - September 2025)
President, Group CEO and Board Member @ (January 2020 - February 2024)
Board Member @ (July 2020 - August 2021)
President and CEO SteadyMed; A United Therapeutics Company (Nasdaq; UTHR) @ United Therapeutics (September 2018 - January 2020)
Chairman of the Board @ CollPlant Biotechnologies (December 2018 - December 2019)
Member Board of Directors, Audit Committee and Chairman of the Nominating and Governance Committee @ Xeris Pharmaceuticals (NASDAQ: XERS) (March 2016 - April 2019)
President, CEO and Board Member SteadyMed (NASDAQ; STDY) @ (January 2011 - August 2018)
Co Founder and VP Business Development @ Zogenix Inc, (Nasdaq; ZGNX) (August 2006 - December 2010)
Vice President Business Development and Licensing @ Aradigm Corporation (Nasdaq: ARDM) (January 2002 - January 2006)
Head Business Development and UK Sales and Marketing @ Profile Therapeutics / Phillips Medical (July 1995 - June 2002)
Various @ Merck, Bristol Myers Squibb (January 1990 - January 1995)
Jonathan Rigby Education
The University of Sheffield
Biological Sciences (Honors)
1986-1990
University of Portsmouth
Master of Business Administration - MBA
IronMan Triathlon
11 Times
Jonathan Rigby Skills
Biopharmaceuticals
Biotechnology
Board of Directors
Business Dev
Business Development
Business Strategy
CEOs
CRO
Clinical Development
Clinical Research
Clinical Trials
Commercialization
Cross-functional Team Leadership
Drug Delivery
Drug Development
Drug Discovery
Executive Management
FDA
GMP
IPO
Infectious Diseases
Licensing
Life Sciences
Lifesciences
Management
Marketing
Medical Devices
Mergers & Acquisitions
Neurology
Oncology
Pharmaceutical Industry
Pharmaceutical Sales
Pharmaceutics
Product Development
Product Launch
R&D
Regulatory Affairs
Regulatory Submissions
Start-ups
Strategic Alliances
Strategic Leadership
Strategic Planning
Strategy
Team Leadership
Technology Transfer
Vaccines
Validation
financing
investor
leadership
Jonathan Rigby Summary
Jonathan Rigby, based in Cambridge, MA, US, is currently a Board Member and Chief Executive Officer at Sernova Biotherapeutics (SVA.TO). Jonathan Rigby brings experience from previous roles at Sernova (SVA.TO), ReAlta Life Sciences, Exciting Instruments and Oncolytics Biotech Inc. (Nasdaq: ONCY). Jonathan Rigby holds a 1986 - 1990 Biological Sciences (Honors) @ The University of Sheffield. With a robust skill set that includes Biopharmaceuticals, Biotechnology, Board of Directors, Business Dev, Business Development and more. Jonathan Rigby has 2 emails and 5 mobile phone numbers on RocketReach.
Looking for a different Jonathan Rigby?
Find contact details for 700 million professionals.